Apnimed clinical trials we track

Check company identity source

Phase 3 3 trials

Phase 2 5 trials

TrialDrugs studiedStatusPrimary completion
Study That Tests AD109 in Patients Taking GLP-1 DrugsNCT06400615AD109Completed2024-12-26Actual
AD816 Crossover StudyNCT05793684Period A, Period B, Period CCompleted2023-11-09Actual
Trial of AD113 and Atomoxetine in OSA Patients With HypertensionNCT04905979AD113, AtomoxetineCompleted2023-01-31Actual
Parallel Arm Trial of AD109 and AD504 In Patients With OSANCT05071612AD109, AD504, Atomoxetine HydrochlorideCompleted2022-07-20Actual
Crossover Trial of AD036 in Obstructive Sleep ApneaNCT04445688AD036, AtomoxetineCompleted2020-12-01Actual

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline in Apnea-Hypopnea Index (AHI) Description: AHI, Apnea-Hypopnea Index, is the number of apneas or hypopneas recorded via polysomnography during the study per hour of sleep. Apnea is defined as a cessation of airflow lasting at least 10 seconds, hypopnea as a decrease in airflow by at least 30% from baseline for at least 10 seconds occurring with a drop in oxygen saturation (SpO2) by at least 4%. Time frame: 6 months. After: Measure: Change From Baseline in Apnea-Hypopnea Index (AHI) Description: AHI, Apnea-Hypopnea Index, is the number of apneas or hypopneas recorded via polysomnography during the study per hour of sleep. Apnea is defined as a cessation of airflow lasting at least 10 seconds, hypopnea as a decrease in airflow by at least 30% from baseline for at least 10 seconds occurring with a drop in oxygen saturation (SpO2) by at least 4%. Time frame: 6 months.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline in Apnea-Hypopnea Index (AHI). After: Measure: Change From Baseline in Apnea-Hypopnea Index (AHI).

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in AHI, Combined AD109 Dose Arms vs. Combined Placebo Arms. After: Measure: Change in Apnea-Hypopnea Index (AHI4) From Baseline: Combined AD109 Arms vs. Placebo.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in AHI, combined AD109 dose arms vs. combined placebo arms. After: Measure: Change in AHI, Combined AD109 Dose Arms vs. Combined Placebo Arms.

Check registry source